These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1186 related articles for article (PubMed ID: 35368663)

  • 1. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
    Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
    Front Genet; 2022; 13():966896. PubMed ID: 36186456
    [No Abstract]   [Full Text] [Related]  

  • 3. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
    Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
    Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma.
    Zeng C; Yu H; Liu X; Liu Q; Jin J
    Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A methylation-related lncRNA-based prediction model in lung adenocarcinomas.
    Yang K; Liu H; Li JH
    Clin Respir J; 2024 Aug; 18(8):e13753. PubMed ID: 39187946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs.
    Yalimaimaiti S; Liang X; Zhao H; Dou H; Liu W; Yang Y; Ning L
    BMC Bioinformatics; 2023 Mar; 24(1):81. PubMed ID: 36879187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
    Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
    Front Genet; 2022; 13():938250. PubMed ID: 36561319
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs.
    Peng L; Ji J; Zhang C; Wu Z; Sun Y; Fan K; Du W; Liu A; Jiao W
    J Thorac Dis; 2022 Oct; 14(10):3955-3974. PubMed ID: 36389299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and experimental validation of a necroptosis-related lncRNA signature as a prognostic model and immune-landscape predictor for lung adenocarcinoma.
    Zhang T; Hei R; Huang Y; Shao J; Zhang M; Feng K; Qian W; Li S; Jin F; Chen Y
    Am J Cancer Res; 2023; 13(9):4418-4433. PubMed ID: 37818057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
    Front Genet; 2022; 13():838624. PubMed ID: 35928454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a RNA-Seq Based Prognostic Signature with Seven Immune-Related lncRNAs for Lung Adenocarcinoma.
    You J; Fang W; Zhao Q; Chen L; Chen L; Chen F
    Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA.
    Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W
    Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs.
    Diao X; Guo C; Li S
    Front Genet; 2022; 13():833362. PubMed ID: 35938013
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
    Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
    BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma.
    Fang X; Huang E; Xie X; Yang K; Wang S; Huang X; Song M
    Front Genet; 2022; 13():951311. PubMed ID: 36406130
    [No Abstract]   [Full Text] [Related]  

  • 16. A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma.
    Li Q; Wang T; Zhu J; Zhang A; Wu A; Zhou Y; Shi J
    Ann Transl Med; 2023 Mar; 11(5):198. PubMed ID: 37007546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma.
    Chen JH; Wu X; Wang ZM; Liu ZY; He BX; Song WP; Zhang WZ
    J Thorac Dis; 2023 Mar; 15(3):1373-1386. PubMed ID: 37065578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
    Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Liang X; Yao Y
    J Thorac Dis; 2021 Feb; 13(2):720-734. PubMed ID: 33717544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
    Hu J; Wang T; Chen Q
    Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma.
    Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; Abrão FC; Puthamohan VM; Liu L; Jiang T
    Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.